Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,782.81
(
2.51%
)
US TECH 100
24,180.80
(
2.71%
)
Dow Jones
47,909.92
(
2.85%
)
Brent Oil
95.22
(
0.41%
)
Bitcoin
70,931.82
(
-0.28%
)
News Focus
News Focus
Post# of 820846
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

biosectinvestor

Send PM Follow Ignore
Followers 200
Posts 25584
Boards Moderated 0
Alias Born 04/03/2010

biosectinvestor

Re: hankmanhub post# 389239

Wednesday, 07/14/2021 11:11:40 AM

Wednesday, July 14, 2021 11:11:40 AM

Post# of 820846
Why would it not? I don’t get your point. They went through the trouble of going back and getting this data. They did so because they noted that their long-tail patients had certain biomarkers. How is it possible that you would consider biomarkers irrelevant? Could you please explain?

I mean Keytruda has a general approval for any tumor based primarily on certain biomarkers being present. Why would you suggest this is irrelevant?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News